These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1361227)

  • 1. Symposium on Enzyme Inhibition and Drug Discovery. Antwerp, Belgium, 6 November 1992. Abstracts.
    Pharm Weekbl Sci; 1992 Dec; 14(6 Suppl I):I1-13. PubMed ID: 1361227
    [No Abstract]   [Full Text] [Related]  

  • 2. Keystone symposium. Discovery of therapeutic agents. Lake Tahoe, California, March 9-15, 1995. Abstracts.
    J Cell Biochem Suppl; 1995; 19B():347-56. PubMed ID: 7731241
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug Analysis '98. Joint meeting of the 6th International Symposium on Drug Analysis and 9th International Symposium on Pharmaceutical and Biomedical Analysis. Brussels, Belgium, 11-15 May 1998. Abstracts.
    J Pharm Belg; 1998; 53(3):113-271. PubMed ID: 9781423
    [No Abstract]   [Full Text] [Related]  

  • 4. Keystone symposium. Drug delivery: barriers to drug transport and the design of novel therapeutic agents. Hilton Head Island, South Carolina, January 7-13, 1995. Abstracts.
    J Cell Biochem Suppl; 1995; 19A():163-79. PubMed ID: 7731225
    [No Abstract]   [Full Text] [Related]  

  • 5. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery.
    Nair V; Shu Q
    Antivir Chem Chemother; 2007; 18(5):245-58. PubMed ID: 18046958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists.
    Copeland RA
    Methods Biochem Anal; 2005; 46():1-265. PubMed ID: 16350889
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic analysis in drug discovery.
    Cárdenas ML; Cornish-Bowden A
    Science; 2000 Apr; 288(5466):618-9. PubMed ID: 10798998
    [No Abstract]   [Full Text] [Related]  

  • 8. 5th International Symposium on Drug Analysis. Leuven, Belgium, 12-15 September 1995. Abstracts.
    J Pharm Belg; 1995; 50(4):277-424. PubMed ID: 8558404
    [No Abstract]   [Full Text] [Related]  

  • 9. Conference report: 9th International Symposium on Drug Analysis.
    Furlanetto S; Mascini M
    Bioanalysis; 2011 Feb; 3(3):269-70. PubMed ID: 21320046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of an Aurora kinase inhibitor through site-specific dynamic combinatorial chemistry.
    Cancilla MT; He MM; Viswanathan N; Simmons RL; Taylor M; Fung AD; Cao K; Erlanson DA
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3978-81. PubMed ID: 18579375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of thiophene inhibitors of polo-like kinase.
    Emmitte KA; Andrews CW; Badiang JG; Davis-Ward RG; Dickson HD; Drewry DH; Emerson HK; Epperly AH; Hassler DF; Knick VB; Kuntz KW; Lansing TJ; Linn JA; Mook RA; Nailor KE; Salovich JM; Spehar GM; Cheung M
    Bioorg Med Chem Lett; 2009 Feb; 19(3):1018-21. PubMed ID: 19097784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel and potent aryl diamines as leukotriene A4 hydrolase inhibitors.
    Khim SK; Bauman J; Evans J; Freeman B; King B; Kirkland T; Kochanny M; Lentz D; Liang A; Mendoza L; Phillips G; Tseng JL; Wei RG; Ye H; Yu L; Parkinson J; Guilford WJ
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3895-8. PubMed ID: 18590959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abstracts of the Third National Poct Symposium, Antwerp, Belgium, March 17th, 2017.
    Acta Clin Belg; 2017 Nov; 72(sup1):1-14. PubMed ID: 29199548
    [No Abstract]   [Full Text] [Related]  

  • 14. Development and evaluation of a pharmacophore model for inhibitors of aldosterone synthase (CYP11B2).
    Ulmschneider S; Negri M; Voets M; Hartmann RW
    Bioorg Med Chem Lett; 2006 Jan; 16(1):25-30. PubMed ID: 16246562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a novel series of Notch-sparing gamma-secretase inhibitors.
    Kreft A; Harrison B; Aschmies S; Atchison K; Casebier D; Cole DC; Diamantidis G; Ellingboe J; Hauze D; Hu Y; Huryn D; Jin M; Kubrak D; Lu P; Lundquist J; Mann C; Martone R; Moore W; Oganesian A; Porte A; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Woller K; Xu Z; Zhou H; Steven Jacobsen J
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4232-6. PubMed ID: 18556202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors.
    Qiao L; Baumann CA; Crysler CS; Ninan NS; Abad MC; Spurlino JC; Desjarlais RL; Kervinen J; Neeper MP; Bayoumy SS; Williams R; Deckman IC; Dasgupta M; Reed RL; Huebert ND; Tomczuk BE; Moriarty KJ
    Bioorg Med Chem Lett; 2006 Jan; 16(1):123-8. PubMed ID: 16236500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput screening of enzyme inhibition using an inhibitor gradient generated in a microchannel.
    Garcia E; Hasenbank MS; Finlayson B; Yager P
    Lab Chip; 2007 Feb; 7(2):249-55. PubMed ID: 17268628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug analysis. The Third International Symposium. May 1989, Antwerp, Belgium.
    J Pharm Biomed Anal; 1989; 7(12):1291-935. PubMed ID: 2577446
    [No Abstract]   [Full Text] [Related]  

  • 19. Abstracts ESCP Symposium 17-18 May 2019, Antwerp, Belgium.
    Int J Clin Pharm; 2019 Oct; 41(5):1379-1390. PubMed ID: 31254150
    [No Abstract]   [Full Text] [Related]  

  • 20. Quinazolin-2-ylamino-quinazolin-4-ols as novel non-nucleoside inhibitors of bacterial DNA polymerase III.
    Guiles J; Sun X; Critchley IA; Ochsner U; Tregay M; Stone K; Bertino J; Green L; Sabin R; Dean F; Dallmann HG; McHenry CS; Janjic N
    Bioorg Med Chem Lett; 2009 Feb; 19(3):800-2. PubMed ID: 19109016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.